Pharmaceutical News

RSS

Cannabis legalization likely to reduce conventional pharmaceutical sales by billions of dollars

Researchers from California Polytechnic State University and The University of New Mexico find that stock market investors predict cannabis legalization will reduce conventional pharmaceutical sales by billions of dollars.

2 Sep 2022

Globalization and cessation of smallpox vaccination are influencing monkeypox spread

A recent review by Barbara S. Schnierle of the Paul-Ehrlich-Institut, Germany, and published in the journal Viruses summarized the existing knowledge about MPXV, the disease it causes, and the strategies to curb its spread.

1 Sep 2022

Dolutegravir-based regimen more effective for treating pregnant people with HIV-1

Dolutegravir-based antiretroviral therapies (ART) for HIV-1 are more effective for pregnant people than some other ART regimens commonly used in the U.S. and Europe, according to a study led by Harvard T.H. Chan School of Public Health researchers.

1 Sep 2022

Leukemia drug successfully disrupts HER2-positive brain metastasis in animal studies

In animal studies led by researchers at Duke Cancer Institute, a drug approved to treat leukemia successfully disrupted the ability of HER2-positive breast cancer tumors from colonizing the brain.

30 Aug 2022

Naturally occurring compound possesses antibacterial activity against several microorganisms

University researchers have found a naturally occurring compound, known as hydroquinine, has bacterial killing activity against several microorganisms.

30 Aug 2022

EEG tests reveal fentanyl's effects on the brain

Fentanyl is used to supplement sedation and to relieve severe pain during and after surgery, but it's also one of the deadliest drugs of the opioid epidemic.

30 Aug 2022

Research reveals administration of ineffective COVID-19 treatments after FDA deauthorization

Monoclonal antibodies are laboratory-designed treatments tailor-made to fight specific infections. In early 2021, the U.S. Food & Drug Administration issued emergency use authorization for two monoclonal antibodies (bamlanivimab/etesevimab and casirivimab/imdevimab) for the treatment of mild to moderate COVID-19 in high-risk, non-hospitalized patients.

30 Aug 2022

mRNA COVID boosters are effective against severe Omicron for at least six months

A new study published in the journal JAMA Network Open aimed to analyze the association of the types of vaccine and their combination with the waning of protection against Omicron in residents of Singapore who were aged 30 years and above and had received at least two doses of a COVID vaccine.

30 Aug 2022

Full-dose anticoagulation lowers the risk of blood clotting complications in COVID-19 patients

A clinical trial of patients with COVID-19 led by investigators at the TIMI Study Group at Brigham and Women's Hospital and the Critical Care Cardiology Trials Network has found that full-dose anticoagulation lowers the risk of blood clotting complications compared with standard-dose prophylactic anticoagulation.

29 Aug 2022

TTUHSC scientist receives U.S. patent to produce novel nanoantibiotics

According to the Centers for Disease Control and Prevention, more than 2.8 million Americans contract antibiotic-resistant bacterial infections each year, and approximately 35,000 of those patients do not survive their infection.

29 Aug 2022

Study compares the benefits of taking antihypertensive medication in the morning or evening

A pragmatic randomised trial in more than 21,000 patients with high blood pressure followed for over five years has concluded that protection against heart attack, stroke and vascular death is not affected by whether antihypertensive medications are taken in the morning or evening.

26 Aug 2022

The risk of adverse reactions when herbal medications are taken with cancer drugs

A new study discusses phytovigilance initiatives based on the real-world use of herbal drugs in cancer along with conventional chemotherapy.

24 Aug 2022

Glucokinase activator AZD1656 shows potential benefit for diabetics with moderate to severe COVID-19

A new study examines the potential benefit of the glucokinase activator molecule AZD1656 in the ARCADIA trial.

23 Aug 2022

Updated guidelines on the Valneva SARS-CoV-2 vaccine

The WHO provides interim guidelines for the use of the Valneva vaccine.

23 Aug 2022

Medical marijuana users more likely to also use nicotine products

People who use therapeutic cannabis are more likely to also use nicotine products than the general population, according to a Rutgers study.

23 Aug 2022

Direct acting antiviral medications for hepatitis C may improve PTSD symptoms

More than six percent of Americans will develop posttraumatic stress disorder (PTSD) in their lifetime. This potentially chronic condition disrupts lives, and can lead to or exacerbate existing health issues such as depression, anxiety, eating disorders, and suicidal thoughts.

22 Aug 2022

Medical cannabis patients may not be getting consistent guidance from clinicians, analysis suggests

Due to a lack of publicly available data, understanding what products medical cannabis patients use for various conditions has mostly come from survey responses.

22 Aug 2022

Study finds a declining trend in use of medications for sleep disturbance among Americans

Americans aren't turning to pharmaceutical options as often in the never-ending battle for a good night's sleep.

16 Aug 2022

Financial incentives from pharma companies can influence how vision care practitioners prescribe branded eyedrops

In a lookback study of prescribing patterns among thousands of American ophthalmologists and optometrists, Johns Hopkins Medicine researchers concluded that eye doctors who receive even small financial incentives from pharmaceutical companies, such as free food, sponsored travel to attend meetings or consulting fees, are up to twice as likely to prescribe the companies' brand name eyedrops for glaucoma instead of cheaper generic versions.

15 Aug 2022

ACR appreciates the passage of key drug pricing reforms in the Inflation Reduction Act

The American College of Rheumatology today applauded the passage of key drug pricing reforms in the Inflation Reduction Act that will improve rheumatology patients' access to needed drug therapies and treatments.

15 Aug 2022

Previous
1
...
89
90
91
92
93
94
95
...
1453
Next

Pharmaceutical News

Cannabis legalization likely to reduce conventional pharmaceutical sales by billions of dollars

Globalization and cessation of smallpox vaccination are influencing monkeypox spread

Dolutegravir-based regimen more effective for treating pregnant people with HIV-1

Leukemia drug successfully disrupts HER2-positive brain metastasis in animal studies

Naturally occurring compound possesses antibacterial activity against several microorganisms

EEG tests reveal fentanyl's effects on the brain

Research reveals administration of ineffective COVID-19 treatments after FDA deauthorization

mRNA COVID boosters are effective against severe Omicron for at least six months

Full-dose anticoagulation lowers the risk of blood clotting complications in COVID-19 patients

TTUHSC scientist receives U.S. patent to produce novel nanoantibiotics

Study compares the benefits of taking antihypertensive medication in the morning or evening

The risk of adverse reactions when herbal medications are taken with cancer drugs

Glucokinase activator AZD1656 shows potential benefit for diabetics with moderate to severe COVID-19

Updated guidelines on the Valneva SARS-CoV-2 vaccine

Medical marijuana users more likely to also use nicotine products

Direct acting antiviral medications for hepatitis C may improve PTSD symptoms

Medical cannabis patients may not be getting consistent guidance from clinicians, analysis suggests

Study finds a declining trend in use of medications for sleep disturbance among Americans

Financial incentives from pharma companies can influence how vision care practitioners prescribe branded eyedrops

ACR appreciates the passage of key drug pricing reforms in the Inflation Reduction Act

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News